Literature DB >> 22039930

Panax ginseng, Rhodiola rosea and Schisandra chinensis.

Shun-Wan Chan1.   

Abstract

Panax ginseng (Ginseng), Rhodiola rosea (Hong Jing Tian) and Schisandra chinensis (Wu Wei Zi) are well-known herbs in traditional Chinese medicine (TCM). Recently, there have been a number of studies on these three herbs. This review discusses their active components and major pharmacological effects. For P. ginseng, it has been shown to have an anti-inflammatory activity, affects pulmonary function and erectile dysfunction, improves cognition in patients with Alzheimer's disease and promotes sexual arousal in menopausal women as well as prevents cancer. For R. rosea, its effectiveness in alleviating depression and reducing fatigue is summarized in this review. Additionally, anti-cancer and other clinical effects of S. chinensis are also discussed. These three herbs are considered as adaptogens as they bear multiple functions and their effects were found to be very different in patients depending on the circumstances (age, gender, environment, diet, season, etc.). Thus, in most cases, the art of the TCM practitioner is to prescribe these herbs after a complete evaluation of overall heath status of the patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22039930     DOI: 10.3109/09637486.2011.627840

Source DB:  PubMed          Journal:  Int J Food Sci Nutr        ISSN: 0963-7486            Impact factor:   3.833


  18 in total

1.  Unraveling the action mechanism of polygonum cuspidatum by a network pharmacology approach.

Authors:  Boyu Pan; Xiaona Shi; Tingting Ding; Liren Liu
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

2.  Pesticide residue monitoring and risk assessment in the herbal fruits Schisandra chinensis, Lycium chinense, and Cornus officinalis in Korea.

Authors:  Junheon Kim; Jihye Shin; Chung Gyoo Park; Sang-Hyun Lee
Journal:  Food Sci Biotechnol       Date:  2020-11-04       Impact factor: 2.391

3.  Allicin inhibits oxidative stress-induced mitochondrial dysfunction and apoptosis by promoting PI3K/AKT and CREB/ERK signaling in osteoblast cells.

Authors:  Guoliang Ding; Jianquan Zhao; Dianming Jiang
Journal:  Exp Ther Med       Date:  2016-03-23       Impact factor: 2.447

4.  Synergy and Antagonism of Active Constituents of ADAPT-232 on Transcriptional Level of Metabolic Regulation of Isolated Neuroglial Cells.

Authors:  Alexander Panossian; Rebecca Hamm; Onat Kadioglu; Georg Wikman; Thomas Efferth
Journal:  Front Neurosci       Date:  2013-02-20       Impact factor: 4.677

5.  Anti-Fatigue Effects of Fermented Rhodiola rosea Extract in Mice.

Authors:  Dong-Zhou Kang; Hee-Do Hong; Kyung-Im Kim; Sang Yoon Choi
Journal:  Prev Nutr Food Sci       Date:  2015-03-31

6.  Antihyperglycemic action of rhodiola-aqeous extract in type1-like diabetic rats.

Authors:  Chiang-Shan Niu; Li-Jen Chen; Ho-Shan Niu
Journal:  BMC Complement Altern Med       Date:  2014-01-13       Impact factor: 3.659

7.  Engineering salidroside biosynthetic pathway in hairy root cultures of Rhodiola crenulata based on metabolic characterization of tyrosine decarboxylase.

Authors:  Xiaozhong Lan; Kai Chang; Lingjiang Zeng; Xiaoqiang Liu; Fei Qiu; Weilie Zheng; Hong Quan; Zhihua Liao; Min Chen; Wenlin Huang; Wanhong Liu; Qiang Wang
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

8.  Ginsenoside Rh2 induces human hepatoma cell apoptosisvia bax/bak triggered cytochrome C release and caspase-9/caspase-8 activation.

Authors:  Xiao-Xi Guo; Qiao Guo; Yang Li; Seung Ki Lee; Xue-Ning Wei; Ying-Hua Jin
Journal:  Int J Mol Sci       Date:  2012-11-22       Impact factor: 5.923

9.  Mood disorders and complementary and alternative medicine: a literature review.

Authors:  Naseem Akhtar Qureshi; Abdullah Mohammed Al-Bedah
Journal:  Neuropsychiatr Dis Treat       Date:  2013-05-14       Impact factor: 2.570

10.  A review of the phytochemistry and pharmacological activities of raphani semen.

Authors:  Tung-Ting Sham; Ailsa Chui-Ying Yuen; Yam-Fung Ng; Chi-On Chan; Daniel Kam-Wah Mok; Shun-Wan Chan
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-08       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.